Company Profile

Company Description

Annovis Bio, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and other neurological disorders. The company's research targets the underlying mechanisms of these diseases to slow or halt their progression. Its lead drug candidate aims to improve synaptic function and reduce toxic protein accumulation, potentially offering transformative treatments for patients with debilitating conditions. By addressing multiple pathways involved in neurodegeneration, the company strives to provide meaningful therapeutic solutions where current options are limited. Its approach combines scientific rigor with a commitment to improving quality of life for affected individuals.